KARDKardigan Inc. Common Stock

21.02USD-4.50%Mkt Cap: 1.97B $P/E:

Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of…

Key Statistics

Company
Market Cap1.97B $
Enterprise Value1.31B $
Revenue (TTM)
Gross Profit
Net Income (TTM)-191.94M $
Revenue/Share
Last Price21.02 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees241
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-6.47
PEG
EV/EBITDA-4.93
EV/Revenue
P/S
P/B-1.12
EPS (TTM)-2.84
EPS (Forward)-3.13
52W Range
16.2544% of range27.00
52W High27.00 USD
52W Low16.25 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE76.67%
ROA-49.10%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-151.06M $
CapEx (TTM)6.64M $
FCF Margin
FCF Yield
Net Debt-584.25M $
Net Debt/EBITDA2.20
Balance Sheet
Debt/Equity-0.06
Current Ratio8.72
Quick Ratio8.54
Book Value/Sh-18.1370 USD
Cash/Share6.391 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)43.50 USD
Upside (mean)+106.9%
Target Range37.00 USD51.00 USD
$37.00+106.9% to mean$51.00
# Analysts4
Ownership
Shares Out.93.50M
Float51.76M
Insiders33.41%
Institutions77.57%
Short Interest
Short Ratio4.5d
Short % Float2.09%
Short % Out.1.77%
Shares Short1.58M
Short (prev mo.)1.47M
Technical
SMA 5021.98 (-4.4%)
SMA 20021.98 (-4.4%)
Beta
S&P 52W Chg18.16%
Avg Vol (30d)236.09K
Avg Vol (10d)220.74K
Technical Indicators
RSI (14)49.3
MACD-0.2365
MACD Signal-0.3086
MACD Hist.+0.0721
BB Upper22.18 USD
BB Middle20.82 USD
BB Lower19.47 USD
BB Width13.01%
ATR (14)1.627 USD
Vol Ratio (20d)0.80x